RXMD OTCQB: Record Sales! Expansion! Uplisted! Sma
Post# of 1525
(Total Views: 1191)
Posted On: 03/09/2018 12:30:00 PM
RXMD OTCQB: Record Sales! Expansion! Uplisted! Small Preserved SS! 14 State Licences!
Share Structure
Relatively Preserved OS as compared to 2 years ago:
see---
http://www.otcmarkets.com/stock/RXMD/profile
versus historic---
https://web.archive.org/web/20151229173335/ht...MD/profile
Outstanding Shares a/o March 09, 2018 = 370,999,201 (Authorized Shares 500,000,000)
Outstanding Shares a/o D ec 09, 2015 = 352,043,045 (Authorized Shares 500,000,000)
Market cap
Market cap of a company in this sector (Drugs/Pharmaceutical) see:
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
easily reaches 4x the P/S ratio (up to 10x*)...so for an estimated 25M revs in 2018 the RXMD pps fair market value, not even taking its constant market expansion into account, should be 30 cents in a conservative evaluation* (up to 75 cent*).
14 state licenses. Expansion to 50 states
will follow within few years meaning revenue and profit multiplication!
https://ih.advfn.com/p.php?pid=nmona&article=76101390
http://finance.yahoo.com/news/progressive-car...26653.html
Now Licences pending in 3 new states: Utah, Arizona, and Rhode Island https://ih.advfn.com/p.php?pid=nmona&article=76101390
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share
https://www.otcmarkets.com/stock/RXMD/news/Se...?id=185746
MIAMI, March 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces upgraded price target to $0.35 per share from SeeThruEquity.
SeeThruEquity, a premier small and microcap research firm, released an updated analyst report today upgrading Progressive Care’s price target to $0.35 per share. The upgrade is based on recent news of the Company’s intent to acquire a pharmacy in Palm Beach County as well as increased sales, new product and technology development projects, and the acceptance Bitcoin. SeeThruEquity’s report issues analysis on the Company’s current business and releases new sales targets which provide the basis for the upgraded price target for RXMD.
https://finance.yahoo.com/news/seethruequity-...00911.html
“We are excited to see that SeeThruEquity has initiated updated coverage of the Company,” stated S. Parikh Mars, CEO. "We believe that we are executing on our objectives as we take the Progressive Care to the next level. We are humbled by the response to our story and remain focused on delivering results to our patients and shareholders alike.”
Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County
https://www.otcmarkets.com/stock/RXMD/news/Pr...?id=184975
MIAMI, March 02, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has executed a letter of intent to purchase a pharmacy in Palm Beach County.
On March 1, 2018, the Company signed a letter of intent to purchase a pharmacy in Palm Beach County for $300,000. The Company is beginning the due diligence process with anticipated closing to occur in the second quarter of 2018. The acquisition target is located close to major highways in a 3,000 sq. ft facility. The operation has experienced staff, all applicable licenses, commensurate PBM contracts as PharmCo, LLC, and a Parata PASS 500 unit dose packaging system.
The acquisition of this pharmacy in Palm Beach County will facilitate growth by increasing the delivery radius into Martin County which includes Jupiter and Stuart. It will also decrease costs of expansion and increase prescription dispensing efficiency. The location has the adequate facility space to provide the opportunity to develop new processes for long term care services, compounded medications, and tele-pharmacy services.
In anticipation of the acquisition, the Company drew down just under $600,000 from its Chicago Ventures funding facility. These funds will allow the Company to close the transaction as well as provide working capital for additional build out and sales ramp up of the new Palm Beach location.
“We believe this is the opportunity we have been waiting for,” stated S. Parikh Mars, CEO. "We have been rapidly gaining ground in Palm Beach County and this is the missing piece to lasting success in the area. After an exhaustive search, we think that this acquisition will be just the beginning of an aggressive expansion agenda that allows the Company to reach thousands of new doctors and patients who will benefit greatly from the PharmCo pharmacy model.”
S. Parikh Mars, CEO of Progressive Care Inc., Discusses Recent RXMD News and Corp orate Moves in a New Audio Interview with SmallCapVoice.com
https://www.otcmarkets.com/stock/RXMD/news/S-...?id=184832
AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/2-28-18-smallc...e-inc-rxmd.
S. Parikh Mars, CEO of Progressive Care Inc. called in to SmallCapVoice.com, Inc. to discuss the recent news and achievements for the Company. So far in 2018, Progressive Care announced that 23,000 prescriptions were filled during the month of January, generating $1.8 million in net revenues. That is record for the Company and up 34% from the same month in 2017. RXMD is also proud of the work they are accomplishing with Mass Ventures Corp, a Florida company, who has significantly enhanced the digital presence and technology solutions for the company and all subsidiaries. Other important achievements include the expansion into Palm Beach County and the news that its retail pharmacy will officially begin accepting Bitcoin payments.
In the interview, Ms. Mars was asked what she was excited about in 2018 for her Company and she stated, “I think the coolest thing that I am most excited about is our Telepharmacy platform. While it might be hard for someone who has not seen the software or hasn’t interacted with a kiosk yet to imagine how it works, essentially it allows the patient to go to the doctor, come out with a prescription, visit a convenient kiosk, interact directly with a pharmacy technician on the screen, and speak right to a pharmacist remotely and in real time. There is a face to face interaction with a pharmacist to handle any question or concern the patient has without ever having to visit the pharmacy and wait in line. The medication is then delivered directly to patient’s home. All of this is safe, secured through the software, and HIPAA compliant.”
Progressive Care to Accept Bitcoin for its Pharmacy Unit
https://www.otcmarkets.com/stock/RXMD/news/Pr...?id=183568
MIAMI, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that its retail pharmacy will officially begin accepting Bitcoin payments. Customers that choose to pay using Bitcoin will undergo a similar payment process as customers using credit cards or online payment processing platforms such as Paypal.
PharmCo, LLC will use external payment providers, such as BitPay, to process all Bitcoin payments. BitPay compliance analysts approved the pharmacy for Tier 2 volume processing limit on February 14, 2018. Tier 2 provides daily cash settlements in USD and has a $500,000 annual limit. This will allow the pharmacy to reach more customers who are increasingly using cryptocurrencies for daily purchases. Mass Ventures Corp will develop and integrate Bitcoin processing into the Company’s e-commerce platform for seamless ease of use.
“We are committed to evolving the pharmacy both operationally and technologically,” stated S. Parikh Mars, CEO. "PharmCo will be one of the few pharmacies in the country enabling systems for cryptocurrency acceptance. The main purpose of accepting Bitcoin payments is to provide value to the end customer by aligning ourselves with the current lifestyles of a large and rapidly growing demographic using this cryptocurrency within the community.”
Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018
https://www.otcmarkets.com/stock/RXMD/news/Pr...?id=183298
MIAMI, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces record breaking month of January 2018.
PharmCo, LLC filled over 23,000 prescriptions during the month of January, generating $1.8 million in net revenues. Prescriptions filled increased by 34% compared to the same month last year and by 10% over the last record breaking month in October 2017. Revenues increased by approximately 9% as compared to January 2017. The company also filled over $450,000 worth of prescriptions (not included in Net Revenues) for 340B entities in January, generating fees to the pharmacy of just over $20,000. Current growth has been driven by expansion into Palm Beach County, the digital marketing campaign with Mass Ventures Corp, proficiency of medication therapy management and adherence programs, and the visibility of the pharmacy’s 5 star service rating among physicians and patients throughout South Florida.
“We are thrilled about the fast start to 2018,” stated S. Parikh Mars, CEO. "We are just beginning to see the results from the groundwork we laid in 2017. Over the past 12 months, we have strategically positioned ourselves to take advantage of the changing trends in the healthcare industry. Today, more physicians than ever before are recognizing the impact PharmCo and its model has on their bottom line. They are increasingly seeking out our services to improve patient outcomes and increase profitability.”
Common Shares Issued and Outstanding:
As of February 13, 2018 the number shares of common stock issued and outstanding stood at 365,408,769 shares. This amount is net of the number of shares owned by PharmCo, LLC of 1,718,000. The Company has fully paid off its first installment from Chicago Venture Partners. The Company paid approximately $130,000 in cash and $150,000 in stock. Total shares issued to Chicago Venture Partners was 19,863,662.
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions
https://ih.advfn.com/p.php?pid=nmona&article=76552057
MIAMI, January 25, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has engaged Mass Ventures Corp, a Florida company, to enhance the digital presence and technology solutions of the company and all subsidiaries.
Progressive Care engages Mass Ventures Corp to initiate a digital marketing campaign for both Progressive Care and PharmCo, LLC. The principle of Mass Ventures will be located on-site to provide real-time updates as needed. The campaign consists of many features including, but not limited to, website upgrades, enhanced and updated content, blog posting, social media development, press release distribution, search engine optimization, etc. Mass Ventures is also in the process of developing the Company’s e-commerce platform which will be capable of accepting all payment methods including cryptocurrencies such as Bitcoin. These measures are taken to coincide with the overall technological development of the company to improve the efficacy and exposure of the Company’s public information and virtual interaction with its shareholders and customers.
“The Mass Ventures Corp team has worked with us for over 5 years,” stated S. Parikh Mars, CEO. “We are excited to bring them on-site and begin a transformation of our online presence, as well as creating technology solutions that will modernize all areas of our enterprise. We believe that efforts in this area will make a difference in how we set ourselves apart as a company of the future. This will change how our shareholders and customers perceive and interact with us. Already, we are seeing the impact this project has had on our customer engagement and market awareness.”
“Progressive Care and PharmCo, LLC are ripe for exponential growth and success.” says Marcello Jaspan, owner and operator at MVC . “We are thrilled about the opportunity to serve such an amazing group and to work closely to create engagement and social buzz. On the technical side, we have infinite possibilities for expansion. We started with the launch of Tele-Pharmco, and we will soon have many Apps for customers and internal logistics alike. We will have goodies for everyone coming real soon, all aimed at making everyone’s lives easier and more enjoyable.”
Progressive Care Continues to Break Records with Over $20 Million in Sales
http://www.otcmarkets.com/stock/RXMD/news/Pro...50&b=y
MIAMI, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $20 million in net revenues on approximately 225,000 prescriptions filled in 2017.
PharmCo, LLC filled over 19,500 prescriptions during the month of December, generating approximately $1.6 million in net revenues. Prescriptions filled increased by approximately 8% over the same month last year. The company also filled over $360,000 (not included in net revenues) worth of prescriptions for 340B entities in December, generating fees to the pharmacy of over $15,000.
The company has been successful in breaking records in 2017. The company announced over $20 million in net revenues, an 11% increase over 2016. The company is expecting to achieve increased growth through 2018 as well as continued reporting of strong operational and financial performance. These all-time high sales figures indicate a positive outlook for the company into the coming year.
During the Earnings Call held on November 14, 2017, S. Parikh Mars (CEO), discussed avenues of expansion and advancement for the company during the coming year. In addition to record breaking sales, the company has been successful in its efforts to upgrade its OTCMarkets listing tier to OTCQB. The sales reported are recognized from diversified revenue streams and ongoing development of the Company’s portfolio of healthcare services. Innovation is also a factor as the company launched numerous new and exciting programs in 2017, such as its tele-pharmacy platform.
“2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO. "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”
S. Parikh Mars, CEO of Progressive Care Inc., Provides Progress Report and Outlook for Investors in New Audio Interview at SmallCapVoice.com
www.otcmarkets.com/stock/RXMD/news/S--Parikh-Mars--CEO-of-Progressive-Care-Inc---Provides-Progress-Report-and-Outlook-for-Investors-in-New-Audio-Interview-at-SmallCapVoice-com?id=179764&b=y
AUSTIN, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (The “Company”) (OTCQB:RXMD), today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/1-4-18-smallca...e-inc-rxmd.
S. Parikh Mars, CEO, called in to SmallCapVoice.com to discuss the business model and markets for the company, the recent news and milestones achieved in 2017, what investors can expect from the Company in 2018, and more. In December 2017 the Company announced over $1.7 million in net revenues on nearly 21,000 prescriptions filled in November 2017. A major corporate milestone was also achieved in December as the Company was listed on a higher exchange, the OTC QB.
In the interview, Ms. Mars stated, “As experts in the pharmacy space, we market ourselves primarily to healthcare providers who are looking for pharmacies who they can recommend to their patients knowing that their patients will be well taken care of. We understand that the leading cause of ER visits and readmissions stems from a failure to adhere to a medication regiment and that affects healthcare costs and bottom lines across the healthcare system. By managing this risk, we deliver approved health outcomes to patient and lower health care costs to providers and insurance companies. This has allowed us to develop a solid reputation as a five-star pharmacy which has been a primary driver of increased sales and growth.”
For the video version of this interview, please visit https://youtu.be/oaylHtfuMgc.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-d...ewsletter/.
Progressive Care Announces Uplist to OTCQB
http://www.otcmarkets.com/stock/RXMD/news/Pro...41&b=y
MIAMI, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces OTC Markets approval for uplist to OTCQB effective December 5, 2017.
As of Tuesday, December 5 2017, Progressive Care will trade on OTCQB Venture Market for early stage and developing U.S. and international companies. The Company received approval for the change in listing tier after supplying OTC Markets with all mandatory documents and information, adding independent board members, adding a majority independent audit committee, and providing audited financial statements for 2016. Investors can still find Real-Time quotes and market information for the Company on www.otcmarkets.com (OTCQB:RXMD).
“We have been preparing for this moment since the requirements for OTCQB were announced earlier this year,” stated S. Parikh Mars, CEO. “We continue to take pride in delivering current and complete information to the public and we believe that the change in listing tier will bring our company to a fresh audience and a new level of investor confidence. We are excited to begin rounding out the year on such a positive note.”
Progressive Care Reports Stellar Third Quarter Results[/b]
https://ih.advfn.com/p.php?pid=nmona&article=76101390
MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces financial results for the third quarter and provides updates on the Company’s strategies.
The company dispensed a total of 163,000 prescriptions during the nine months ended September 30, 2017, an increase of 2.5%. Revenues for the third quarter increased 5% to just over $5.1 million. Revenues increased 14% for the nine months ended September 30, 2017 to over $15 million. The Company continues to grow its patient base by marketing to doctors’ offices and clinics who refer their patients to the pharmacy. Healthcare providers are increasingly recommending PharmCo because of its high standards of patient care and attention to performance measurements and their implications.
Operating income decreased by approximately $250,000 in 2017 as compared to 2016. Third quarter operating income was negatively impacted primarily by increases in DIR fees. “DIR” stands for “direct and indirect remuneration” and was initially a term coined by the Centers for Medicare and Medicaid Services (CMS) related to the Medicare Part D benefit to address price concessions that would ultimately impact the gross prescription drug costs of Medicare Part D plans that were not captured at the point of sale.
Today, DIR fees are effectively PBM clawbacks of reimbursements based on factors that vary from plan to plan. These fees lack transparency and are extremely difficult to predict and accrue. DIR fees are often applied retroactively, which has caused the cost of DIR fees to be nearly 200% higher than in the second quarter of the year. DIR fees through September 30, 2017 was over $300,000, over half of which was incurred in the third quarter. Some PBMs may reduce or return DIR Fees based on the performance of the pharmacy within their network.
Q & A Updates
New States – The Company has renewed its efforts to acquire state licenses. PharmCo has licenses pending in three new states: Utah, Arizona, and Rhode Island.
Investor Relations – First Look Equities is tasked with PR distribution. Their distribution platform is designed to increase the number of readers of the Company’s press releases and information which would ultimately have a positive impact on trading volume and shareholder value. The Company is also looking to recruit its own in-house IR team that would work to increase shareholder value.
TelePharmacy – The Company is working on a proprietary platform that would deliver technician or pharmacist consultation services direct to patients or healthcare providers through a secure digital live stream. This platform is currently being tested in Century Village of Pembroke Pines and has had an impact on company recognition, brand loyalty, and prescription processing efficiency.
Progressive Care (RXMD) through its 100% owned subsidiaries PharmCo and Smart Medical Alliance is quickly becoming one of South Florida's leading health services organisations
New appointments to the Board of Directors among those Oleg Firer. Oleg Firer is regarded as one of Florida most successful businessman and a Wall Street heavy hitter . He takes companies like Progressive Care (RXMD) to the next level. Check out these awesome recognitions he has received!
http://investorshub.advfn.com/boards/read_msg...=135023809
Progressive Care (RXMD) has been awarded a 5-Star Rating based on the ratings provided by various insurance carriers. Rated among the top 10% of all Pharmaceutic Benefit Networks in the NATION Progressive Care (RXMD) is right there with the big players and a major buyout target.
The ScriptPro Pharmacy Automation System is online and fully operational
http://ih.advfn.com/p.php?pid=nmona&artic...ymbol=RXMD
The Company will ship medications from its Florida facility to other states
http://www.streetinsider.com/Press+Releases/P...08843.html
Share Structure
Relatively Preserved OS as compared to 2 years ago:
see---
http://www.otcmarkets.com/stock/RXMD/profile
versus historic---
https://web.archive.org/web/20151229173335/ht...MD/profile
Outstanding Shares a/o March 09, 2018 = 370,999,201 (Authorized Shares 500,000,000)
Outstanding Shares a/o D ec 09, 2015 = 352,043,045 (Authorized Shares 500,000,000)
Market cap
Market cap of a company in this sector (Drugs/Pharmaceutical) see:
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
easily reaches 4x the P/S ratio (up to 10x*)...so for an estimated 25M revs in 2018 the RXMD pps fair market value, not even taking its constant market expansion into account, should be 30 cents in a conservative evaluation* (up to 75 cent*).
14 state licenses. Expansion to 50 states
will follow within few years meaning revenue and profit multiplication!
https://ih.advfn.com/p.php?pid=nmona&article=76101390
http://finance.yahoo.com/news/progressive-car...26653.html
Now Licences pending in 3 new states: Utah, Arizona, and Rhode Island https://ih.advfn.com/p.php?pid=nmona&article=76101390
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share
https://www.otcmarkets.com/stock/RXMD/news/Se...?id=185746
MIAMI, March 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces upgraded price target to $0.35 per share from SeeThruEquity.
SeeThruEquity, a premier small and microcap research firm, released an updated analyst report today upgrading Progressive Care’s price target to $0.35 per share. The upgrade is based on recent news of the Company’s intent to acquire a pharmacy in Palm Beach County as well as increased sales, new product and technology development projects, and the acceptance Bitcoin. SeeThruEquity’s report issues analysis on the Company’s current business and releases new sales targets which provide the basis for the upgraded price target for RXMD.
https://finance.yahoo.com/news/seethruequity-...00911.html
“We are excited to see that SeeThruEquity has initiated updated coverage of the Company,” stated S. Parikh Mars, CEO. "We believe that we are executing on our objectives as we take the Progressive Care to the next level. We are humbled by the response to our story and remain focused on delivering results to our patients and shareholders alike.”
Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County
https://www.otcmarkets.com/stock/RXMD/news/Pr...?id=184975
MIAMI, March 02, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has executed a letter of intent to purchase a pharmacy in Palm Beach County.
On March 1, 2018, the Company signed a letter of intent to purchase a pharmacy in Palm Beach County for $300,000. The Company is beginning the due diligence process with anticipated closing to occur in the second quarter of 2018. The acquisition target is located close to major highways in a 3,000 sq. ft facility. The operation has experienced staff, all applicable licenses, commensurate PBM contracts as PharmCo, LLC, and a Parata PASS 500 unit dose packaging system.
The acquisition of this pharmacy in Palm Beach County will facilitate growth by increasing the delivery radius into Martin County which includes Jupiter and Stuart. It will also decrease costs of expansion and increase prescription dispensing efficiency. The location has the adequate facility space to provide the opportunity to develop new processes for long term care services, compounded medications, and tele-pharmacy services.
In anticipation of the acquisition, the Company drew down just under $600,000 from its Chicago Ventures funding facility. These funds will allow the Company to close the transaction as well as provide working capital for additional build out and sales ramp up of the new Palm Beach location.
“We believe this is the opportunity we have been waiting for,” stated S. Parikh Mars, CEO. "We have been rapidly gaining ground in Palm Beach County and this is the missing piece to lasting success in the area. After an exhaustive search, we think that this acquisition will be just the beginning of an aggressive expansion agenda that allows the Company to reach thousands of new doctors and patients who will benefit greatly from the PharmCo pharmacy model.”
S. Parikh Mars, CEO of Progressive Care Inc., Discusses Recent RXMD News and Corp orate Moves in a New Audio Interview with SmallCapVoice.com
https://www.otcmarkets.com/stock/RXMD/news/S-...?id=184832
AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/2-28-18-smallc...e-inc-rxmd.
S. Parikh Mars, CEO of Progressive Care Inc. called in to SmallCapVoice.com, Inc. to discuss the recent news and achievements for the Company. So far in 2018, Progressive Care announced that 23,000 prescriptions were filled during the month of January, generating $1.8 million in net revenues. That is record for the Company and up 34% from the same month in 2017. RXMD is also proud of the work they are accomplishing with Mass Ventures Corp, a Florida company, who has significantly enhanced the digital presence and technology solutions for the company and all subsidiaries. Other important achievements include the expansion into Palm Beach County and the news that its retail pharmacy will officially begin accepting Bitcoin payments.
In the interview, Ms. Mars was asked what she was excited about in 2018 for her Company and she stated, “I think the coolest thing that I am most excited about is our Telepharmacy platform. While it might be hard for someone who has not seen the software or hasn’t interacted with a kiosk yet to imagine how it works, essentially it allows the patient to go to the doctor, come out with a prescription, visit a convenient kiosk, interact directly with a pharmacy technician on the screen, and speak right to a pharmacist remotely and in real time. There is a face to face interaction with a pharmacist to handle any question or concern the patient has without ever having to visit the pharmacy and wait in line. The medication is then delivered directly to patient’s home. All of this is safe, secured through the software, and HIPAA compliant.”
Progressive Care to Accept Bitcoin for its Pharmacy Unit
https://www.otcmarkets.com/stock/RXMD/news/Pr...?id=183568
MIAMI, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that its retail pharmacy will officially begin accepting Bitcoin payments. Customers that choose to pay using Bitcoin will undergo a similar payment process as customers using credit cards or online payment processing platforms such as Paypal.
PharmCo, LLC will use external payment providers, such as BitPay, to process all Bitcoin payments. BitPay compliance analysts approved the pharmacy for Tier 2 volume processing limit on February 14, 2018. Tier 2 provides daily cash settlements in USD and has a $500,000 annual limit. This will allow the pharmacy to reach more customers who are increasingly using cryptocurrencies for daily purchases. Mass Ventures Corp will develop and integrate Bitcoin processing into the Company’s e-commerce platform for seamless ease of use.
“We are committed to evolving the pharmacy both operationally and technologically,” stated S. Parikh Mars, CEO. "PharmCo will be one of the few pharmacies in the country enabling systems for cryptocurrency acceptance. The main purpose of accepting Bitcoin payments is to provide value to the end customer by aligning ourselves with the current lifestyles of a large and rapidly growing demographic using this cryptocurrency within the community.”
Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018
https://www.otcmarkets.com/stock/RXMD/news/Pr...?id=183298
MIAMI, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces record breaking month of January 2018.
PharmCo, LLC filled over 23,000 prescriptions during the month of January, generating $1.8 million in net revenues. Prescriptions filled increased by 34% compared to the same month last year and by 10% over the last record breaking month in October 2017. Revenues increased by approximately 9% as compared to January 2017. The company also filled over $450,000 worth of prescriptions (not included in Net Revenues) for 340B entities in January, generating fees to the pharmacy of just over $20,000. Current growth has been driven by expansion into Palm Beach County, the digital marketing campaign with Mass Ventures Corp, proficiency of medication therapy management and adherence programs, and the visibility of the pharmacy’s 5 star service rating among physicians and patients throughout South Florida.
“We are thrilled about the fast start to 2018,” stated S. Parikh Mars, CEO. "We are just beginning to see the results from the groundwork we laid in 2017. Over the past 12 months, we have strategically positioned ourselves to take advantage of the changing trends in the healthcare industry. Today, more physicians than ever before are recognizing the impact PharmCo and its model has on their bottom line. They are increasingly seeking out our services to improve patient outcomes and increase profitability.”
Common Shares Issued and Outstanding:
As of February 13, 2018 the number shares of common stock issued and outstanding stood at 365,408,769 shares. This amount is net of the number of shares owned by PharmCo, LLC of 1,718,000. The Company has fully paid off its first installment from Chicago Venture Partners. The Company paid approximately $130,000 in cash and $150,000 in stock. Total shares issued to Chicago Venture Partners was 19,863,662.
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions
https://ih.advfn.com/p.php?pid=nmona&article=76552057
MIAMI, January 25, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has engaged Mass Ventures Corp, a Florida company, to enhance the digital presence and technology solutions of the company and all subsidiaries.
Progressive Care engages Mass Ventures Corp to initiate a digital marketing campaign for both Progressive Care and PharmCo, LLC. The principle of Mass Ventures will be located on-site to provide real-time updates as needed. The campaign consists of many features including, but not limited to, website upgrades, enhanced and updated content, blog posting, social media development, press release distribution, search engine optimization, etc. Mass Ventures is also in the process of developing the Company’s e-commerce platform which will be capable of accepting all payment methods including cryptocurrencies such as Bitcoin. These measures are taken to coincide with the overall technological development of the company to improve the efficacy and exposure of the Company’s public information and virtual interaction with its shareholders and customers.
“The Mass Ventures Corp team has worked with us for over 5 years,” stated S. Parikh Mars, CEO. “We are excited to bring them on-site and begin a transformation of our online presence, as well as creating technology solutions that will modernize all areas of our enterprise. We believe that efforts in this area will make a difference in how we set ourselves apart as a company of the future. This will change how our shareholders and customers perceive and interact with us. Already, we are seeing the impact this project has had on our customer engagement and market awareness.”
“Progressive Care and PharmCo, LLC are ripe for exponential growth and success.” says Marcello Jaspan, owner and operator at MVC . “We are thrilled about the opportunity to serve such an amazing group and to work closely to create engagement and social buzz. On the technical side, we have infinite possibilities for expansion. We started with the launch of Tele-Pharmco, and we will soon have many Apps for customers and internal logistics alike. We will have goodies for everyone coming real soon, all aimed at making everyone’s lives easier and more enjoyable.”
Progressive Care Continues to Break Records with Over $20 Million in Sales
http://www.otcmarkets.com/stock/RXMD/news/Pro...50&b=y
MIAMI, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $20 million in net revenues on approximately 225,000 prescriptions filled in 2017.
PharmCo, LLC filled over 19,500 prescriptions during the month of December, generating approximately $1.6 million in net revenues. Prescriptions filled increased by approximately 8% over the same month last year. The company also filled over $360,000 (not included in net revenues) worth of prescriptions for 340B entities in December, generating fees to the pharmacy of over $15,000.
The company has been successful in breaking records in 2017. The company announced over $20 million in net revenues, an 11% increase over 2016. The company is expecting to achieve increased growth through 2018 as well as continued reporting of strong operational and financial performance. These all-time high sales figures indicate a positive outlook for the company into the coming year.
During the Earnings Call held on November 14, 2017, S. Parikh Mars (CEO), discussed avenues of expansion and advancement for the company during the coming year. In addition to record breaking sales, the company has been successful in its efforts to upgrade its OTCMarkets listing tier to OTCQB. The sales reported are recognized from diversified revenue streams and ongoing development of the Company’s portfolio of healthcare services. Innovation is also a factor as the company launched numerous new and exciting programs in 2017, such as its tele-pharmacy platform.
“2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO. "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”
S. Parikh Mars, CEO of Progressive Care Inc., Provides Progress Report and Outlook for Investors in New Audio Interview at SmallCapVoice.com
www.otcmarkets.com/stock/RXMD/news/S--Parikh-Mars--CEO-of-Progressive-Care-Inc---Provides-Progress-Report-and-Outlook-for-Investors-in-New-Audio-Interview-at-SmallCapVoice-com?id=179764&b=y
AUSTIN, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (The “Company”) (OTCQB:RXMD), today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/1-4-18-smallca...e-inc-rxmd.
S. Parikh Mars, CEO, called in to SmallCapVoice.com to discuss the business model and markets for the company, the recent news and milestones achieved in 2017, what investors can expect from the Company in 2018, and more. In December 2017 the Company announced over $1.7 million in net revenues on nearly 21,000 prescriptions filled in November 2017. A major corporate milestone was also achieved in December as the Company was listed on a higher exchange, the OTC QB.
In the interview, Ms. Mars stated, “As experts in the pharmacy space, we market ourselves primarily to healthcare providers who are looking for pharmacies who they can recommend to their patients knowing that their patients will be well taken care of. We understand that the leading cause of ER visits and readmissions stems from a failure to adhere to a medication regiment and that affects healthcare costs and bottom lines across the healthcare system. By managing this risk, we deliver approved health outcomes to patient and lower health care costs to providers and insurance companies. This has allowed us to develop a solid reputation as a five-star pharmacy which has been a primary driver of increased sales and growth.”
For the video version of this interview, please visit https://youtu.be/oaylHtfuMgc.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-d...ewsletter/.
Progressive Care Announces Uplist to OTCQB
http://www.otcmarkets.com/stock/RXMD/news/Pro...41&b=y
MIAMI, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces OTC Markets approval for uplist to OTCQB effective December 5, 2017.
As of Tuesday, December 5 2017, Progressive Care will trade on OTCQB Venture Market for early stage and developing U.S. and international companies. The Company received approval for the change in listing tier after supplying OTC Markets with all mandatory documents and information, adding independent board members, adding a majority independent audit committee, and providing audited financial statements for 2016. Investors can still find Real-Time quotes and market information for the Company on www.otcmarkets.com (OTCQB:RXMD).
“We have been preparing for this moment since the requirements for OTCQB were announced earlier this year,” stated S. Parikh Mars, CEO. “We continue to take pride in delivering current and complete information to the public and we believe that the change in listing tier will bring our company to a fresh audience and a new level of investor confidence. We are excited to begin rounding out the year on such a positive note.”
Progressive Care Reports Stellar Third Quarter Results[/b]
https://ih.advfn.com/p.php?pid=nmona&article=76101390
MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces financial results for the third quarter and provides updates on the Company’s strategies.
The company dispensed a total of 163,000 prescriptions during the nine months ended September 30, 2017, an increase of 2.5%. Revenues for the third quarter increased 5% to just over $5.1 million. Revenues increased 14% for the nine months ended September 30, 2017 to over $15 million. The Company continues to grow its patient base by marketing to doctors’ offices and clinics who refer their patients to the pharmacy. Healthcare providers are increasingly recommending PharmCo because of its high standards of patient care and attention to performance measurements and their implications.
Operating income decreased by approximately $250,000 in 2017 as compared to 2016. Third quarter operating income was negatively impacted primarily by increases in DIR fees. “DIR” stands for “direct and indirect remuneration” and was initially a term coined by the Centers for Medicare and Medicaid Services (CMS) related to the Medicare Part D benefit to address price concessions that would ultimately impact the gross prescription drug costs of Medicare Part D plans that were not captured at the point of sale.
Today, DIR fees are effectively PBM clawbacks of reimbursements based on factors that vary from plan to plan. These fees lack transparency and are extremely difficult to predict and accrue. DIR fees are often applied retroactively, which has caused the cost of DIR fees to be nearly 200% higher than in the second quarter of the year. DIR fees through September 30, 2017 was over $300,000, over half of which was incurred in the third quarter. Some PBMs may reduce or return DIR Fees based on the performance of the pharmacy within their network.
Q & A Updates
New States – The Company has renewed its efforts to acquire state licenses. PharmCo has licenses pending in three new states: Utah, Arizona, and Rhode Island.
Investor Relations – First Look Equities is tasked with PR distribution. Their distribution platform is designed to increase the number of readers of the Company’s press releases and information which would ultimately have a positive impact on trading volume and shareholder value. The Company is also looking to recruit its own in-house IR team that would work to increase shareholder value.
TelePharmacy – The Company is working on a proprietary platform that would deliver technician or pharmacist consultation services direct to patients or healthcare providers through a secure digital live stream. This platform is currently being tested in Century Village of Pembroke Pines and has had an impact on company recognition, brand loyalty, and prescription processing efficiency.
Progressive Care (RXMD) through its 100% owned subsidiaries PharmCo and Smart Medical Alliance is quickly becoming one of South Florida's leading health services organisations
New appointments to the Board of Directors among those Oleg Firer. Oleg Firer is regarded as one of Florida most successful businessman and a Wall Street heavy hitter . He takes companies like Progressive Care (RXMD) to the next level. Check out these awesome recognitions he has received!
http://investorshub.advfn.com/boards/read_msg...=135023809
Progressive Care (RXMD) has been awarded a 5-Star Rating based on the ratings provided by various insurance carriers. Rated among the top 10% of all Pharmaceutic Benefit Networks in the NATION Progressive Care (RXMD) is right there with the big players and a major buyout target.
The ScriptPro Pharmacy Automation System is online and fully operational
http://ih.advfn.com/p.php?pid=nmona&artic...ymbol=RXMD
The Company will ship medications from its Florida facility to other states
http://www.streetinsider.com/Press+Releases/P...08843.html
(0)
(0)Progressive Care Inc. (RXMD) Stock Research Links
Scroll down for more posts ▼